MeDi Group is an early-stage but already operational healthcare consolidation platform. Round 1 is closed, LORENT (an ENT clinic in Riga) has been open since June, Vividerm joined in October, and a third deal, in psychiatry, is in deep due diligence. Round 2 targets ~€1m for the next acquisitions in a fragmented market growing 7-9% a year, with the goal of a 4-10 clinic group. We’re targeting dividends from 2029 and a net IRR of 15%+, with a €75k minimum ticket. Terms match Round 1, and the available allocation is shrinking.

Open for investors Healthcare
MeDi Group
Consolidating high cash-flow healthcare businesses across several verticals through M&A and greenfield investments.

Key terms
- Investment vehicle
- Merito Management Target Fund VI
- Size
- 5 mEUR
- Term
- Evergreen, with dividend generation from 2029
- Minimum commitment
- 75 000 EUR
- Target net IRR
- 15 - 20%
- Merito co-investment
- 10%
Interested in MeDi Group?
Leave your details and our investor relations team will get back to you.
Other open opportunities
Real estate
Real Estate Special Situation
Acquire and repurpose real estate in Riga.
- Minimum commitment
- 75 000 EUR
- Term
- 3 Years
- Target net IRR
- 15 - 25%
